All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-ZP262 | anti-Glycoprotein B T cell receptor (Clone 1), pCDTCR1 | HSV-1 | Clone 1 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP263 | anti-Glycoprotein B T cell receptor (Clone 10), pCDTCR1 | HSV-1 | Clone 10 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP264 | anti-Glycoprotein B T cell receptor (Clone 11), pCDTCR1 | HSV-1 | Clone 11 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP265 | anti-Glycoprotein B T cell receptor (Clone 12), pCDTCR1 | HSV-1 | Clone 12 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP266 | anti-Glycoprotein B T cell receptor (Clone 13), pCDTCR1 | HSV-1 | Clone 13 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP267 | anti-Glycoprotein B T cell receptor (Clone 14), pCDTCR1 | HSV-1 | Clone 14 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP268 | anti-Glycoprotein B T cell receptor (Clone 15), pCDTCR1 | HSV-1 | Clone 15 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP269 | anti-Glycoprotein B T cell receptor (Clone 16), pCDTCR1 | HSV-1 | Clone 16 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP270 | anti-Glycoprotein B T cell receptor (Clone 17), pCDTCR1 | HSV-1 | Clone 17 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP271 | anti-Glycoprotein B T cell receptor (Clone 18), pCDTCR1 | HSV-1 | Clone 18 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP272 | anti-Glycoprotein B T cell receptor (Clone 19), pCDTCR1 | HSV-1 | Clone 19 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP273 | anti-Glycoprotein B T cell receptor (Clone 2), pCDTCR1 | HSV-1 | Clone 2 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP274 | anti-Glycoprotein B T cell receptor (Clone 20), pCDTCR1 | HSV-1 | Clone 20 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP275 | anti-Glycoprotein B T cell receptor (Clone 21), pCDTCR1 | HSV-1 | Clone 21 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP276 | anti-Glycoprotein B T cell receptor (Clone 22), pCDTCR1 | HSV-1 | Clone 22 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP277 | anti-Glycoprotein B T cell receptor (Clone 23), pCDTCR1 | HSV-1 | Clone 23 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP278 | anti-Glycoprotein B T cell receptor (Clone 3), pCDTCR1 | HSV-1 | Clone 3 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP279 | anti-Glycoprotein B T cell receptor (Clone 4), pCDTCR1 | HSV-1 | Clone 4 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP280 | anti-Glycoprotein B T cell receptor (Clone 5), pCDTCR1 | HSV-1 | Clone 5 | SSIEFARL | H-2Kb | Lentiviral vector | ||
TCR-ZP281 | anti-Glycoprotein B T cell receptor (Clone 6), pCDTCR1 | HSV-1 | Clone 6 | SSIEFARL | H-2Kb | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION